Top Glucagon-like Peptide-1 Agonists Companies, Leaders & Major Players

This list of the top companies of Glucagon-like Peptide-1 Agonists is drawn from assessments by Mordor Intelligence analysts and expert advisors via their extensive research to identify the brands, leaders and major players active in Glucagon-like Peptide-1 Agonists sector.

Top Glucagon-like Peptide-1 Agonists Companies

  1. AstraZeneca

  2. Eli Lilly and Company

  3. Sanofi

  4. Novo Nordisk

  5. Pfizer

*Disclaimer: Top companies sorted in no particular order

Glucagon-like Peptide-1 Agonists Market Major Players

Glucagon-like Peptide-1 Agonists - Competitive Concentration

Glucagon-like Peptide-1 Agonists Market Concentration

List of Glucagon-like Peptide-1 Agonists Companies

  • Amgen

  • Amylink Bio

  • Ascletis Pharma

  • AstraZeneca

  • Boehringer Ingelheim

  • Eli Lilly and Company

  • Gan & Lee Pharma

  • Hanmi Pharmaceutical

  • Hengrui Pharma

  • Innovent Biologics

  • Novo Nordisk

  • Pfizer

  • Roche

  • Sanofi

  • Structure Therapeutics

  • Terns Pharmaceuticals

  • Viking Therapeutics

  • Zealand Pharma

Get more insights on Glucagon-like Peptide-1 Agonists industry from our comprehensive report

Complete your form and get your market insights delivered to your inbox

Takes less than 10 seconds